Fentanyl Transdermal Patch and Elagolix: Interaction Details
- Elagolix
- Orilissa
- Fentanyl Transdermal Patch
- DuragesicAbstralSubsys +3 more
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Fentanyl Transdermal Patch and Elagolix interaction:
Fentanyl Transdermal Patch
- Duragesic
- Abstral
- Subsys
- Ionsys
- Actiq
- Fentora
What Happens When You Take Fentanyl Transdermal Patch With Elagolix
What can happen when they are taken together (rated Major)
Reduced exposure of fentaNYL, reduced of fentaNYL and/or onset of withdrawal symptoms
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
When fentaNYL is taken together with a , fentaNYL may fall. This can lead to diminished fentaNYL efficacy, or to opioid withdrawal syndrome in a patient who has become physically dependent on fentaNYL.
Should be necessary, the patient should be monitored for signs of opioid withdrawal, and an increase in the fentaNYL dosage may be considered until drug effects are stable. Once the CYP3A4 inducer is stopped, fentaNYL plasma concentrations will rise, which may heighten or prolong both the therapeutic and the adverse effects of fentaNYL, including a risk of serious . When a CYP3A4 inducer is withdrawn, a lower fentaNYL dosage should be considered, and patients should be assessed frequently for signs of respiratory depression and .1432
The Fentanyl Transdermal Patch and Elagolix Interaction, Explained
Elagolix (Orilissa) can speed up how fast your body breaks down fentanyl, the pain medicine in the Duragesic patch. That means less fentanyl may be in your blood, so your pain may not be controlled as well. If your body is used to fentanyl, you could even have withdrawal symptoms like sweating, restlessness, anxiety, or aches.
The reverse matters too. If elagolix is later stopped, fentanyl levels can climb back up, which can cause extra sleepiness or slowed breathing. Please keep using both exactly as prescribed, and tell your pharmacist or doctor about any pain changes or withdrawal-type symptoms. Your care team can adjust your dose and watch you closely to keep you safe and comfortable.
Mechanism: Elagolix is a (weak to moderate). Fentanyl is a CYP3A4 , so may reduce fentanyl exposure (/), with possible loss of analgesic or precipitated withdrawal in physically dependent patients. Fentanyl is not a , so reduced exposure means reduced effect.
- Severity/evidence: Major; probable. Onset unspecified.
- Starting the inducer: Monitor for withdrawal and inadequate analgesia; consider increasing fentanyl dose until stable effect is achieved.
- Stopping the inducer: Fentanyl levels will rise, increasing the risk of and . Consider dose reduction and monitor at frequent intervals.
See the 6 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Fentanyl Transdermal Patch and Elagolix Interact
The likely mechanism
of -mediated of fentaNYL
How to Manage the Fentanyl Transdermal Patch and Elagolix Interaction
Your care team can manage this by tailoring your fentanyl dose and monitoring you more closely.
- Keep using both medicines exactly as prescribed. Do not change or stop either one on your own.
- Tell your pharmacist or prescriber if pain is less controlled or you notice withdrawal symptoms such as sweating, restlessness, or aches.
- If elagolix is ever stopped, your fentanyl dose may need to be lowered, and you may be checked more often for sleepiness or slowed breathing.
- Report unusual drowsiness or slow, shallow breathing right away.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Fentanyl Transdermal Patch or Elagolix need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1
A 64-year-old man who was taking rifAMPin, a strong ,5 could not obtain adequate pain control with optimized doses of transdermal fentaNYL plus rescue analgesics until he was changed to morphine. The patient had colon cancer and was taking rifAMPin 450 mg/day within an antitubercular regimen for pulmonary tuberculosis.
Pain control was not achieved even though the fentaNYL dose was increased from 0.6 mg/day to 2.5 mg/day together with rescue medication. When fentaNYL was replaced with sustained-release oral morphine at a dose with analgesic potency relative to fentaNYL (180 mg/day), pain control was obtained.
Afterward, however, the patient developed a disturbance in consciousness, which was regarded as a morphine side effect. According to the Naranjo probability scale, rifAMPin was a possible cause of the lack of response to fentaNYL.6
Fentanyl Transdermal Patch and Elagolix: Common Questions
How serious is the Fentanyl Transdermal Patch and Elagolix interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Fentanyl Transdermal Patch and Elagolix interaction managed?
Your care team can manage this by tailoring your fentanyl dose and monitoring you more closely. Keep using both medicines exactly as prescribed. Do not change or stop either one on your own. Tell your pharmacist or prescriber if pain is less controlled or you notice withdrawal symptoms such as sweating, restlessness, or aches. If elagolix is ever stopped, your fentanyl dose may need to be lowered,… Management is individual — always follow your own care team's guidance.
Does taking Fentanyl Transdermal Patch and Elagolix at different times of day help?
No. Taking them at different times of day does not prevent this one. Elagolix speeds up , an enzyme that breaks down fentanyl, so fentanyl can be cleared faster. That change lasts while elagolix is being taken and can continue for a while after the last dose.
Your pharmacist or prescriber can tell you how they will manage it.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Fentanyl Transdermal Patch and Elagolix Interaction
Ask in your own words about taking Fentanyl Transdermal Patch and Elagolix together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (6)
- Product Information: DURAGESIC(R) transdermal system, fentanyl transdermal system. Janssen Pharmaceuticals Inc (per manufacturer), Titusville, NJ, 2018. DailyMed
- Product Information: ACTIQ(R) oral transmucosal lozenge, fentanyl citrate oral transmucosal lozenge. Teva Pharmaceuticals USA, Inc. (per FDA), Parsippany, NJ, 2023. DailyMed
- Product Information: Fentanyl citrate intravenous, intramuscular injection, fentanyl citrate intravenous, intramuscular injection. Hospira Inc (per FDA), Lake Forest, IL, 2023. DailyMed
- Product Information: FENTORA(R) buccal tablets, fentanyl citrate buccal tablets. Teva Pharmaceuticals USA Inc (per FDA), Parsippany, NJ, 2023.
- Certara Drug Interactions Solutions: Certara Drug Interaction Database (DIDB(R)). Princeton, NJ: Certara, May 2024.
- Morii H, Chiba M, Konishi H, et al: Failure of pain control using transdermal fentanyl during rifampicin treatment. J Pain Symptom Manage 2007; 33(1):5-6. PubMed
Other Serious Interactions of Fentanyl Transdermal Patch and Elagolix
Also serious with Elagolix
- ColchicineContraindicated
- Cyclosporine InjectionContraindicated
- Cyclosporine OphthalmicContraindicated
- DarolutamideContraindicated
Also serious with Fentanyl Transdermal Patch
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.